Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Aurora Mira"'
Autor:
Sara Cardellini, Chiara Lucrezia Deantoni, Matteo Paccagnella, Amanda Casirati, Andrea Pontara, Alessandro Marinosci, Moreno Tresoldi, Leone Giordano, Anna Chiara, Italo Dell’Oca, Nadia Gisella Di Muzio, Riccardo Caccialanza, Aurora Mirabile
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionChemoradiotherapy in head and neck cancer patients has a curative intent but often deteriorates nutritional status leading to sarcopenia and cachexia.MethodsIn this observational and single-centered study, a prospective evaluation of seve
Externí odkaz:
https://doaj.org/article/836a66d08d5246d6bda54a6dd7f091ba
Autor:
Francesco Trevisani, Federico Di Marco, Giulia Quattrini, Nicola Lepori, Matteo Floris, Davide Valsecchi, Leone Giordano, Italo Dell’Oca, Sara Cardellini, Alessandra Cinque, Aurora Mirabile
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundIn locally advanced head and neck squamous cell carcinoma (LA-SCCHN) at least 200mg/m2 (standard dose 300 mg/m2) of cisplatin concomitant with radiotherapy represents the standard of care, both in postoperative and conservative settings. Ne
Externí odkaz:
https://doaj.org/article/f8212185a94a4a52985dce89a9c9b937
Autor:
Paola Dall’Ara, Stefania Lauzi, Lauretta Turin, Francesco Servida, Laura Barbieri, Jari Zambarbieri, Giulia Mazzotti, Federico Granatiero, Elena Scarparo, Aurora Mirabile, Stefano Bo, Joel Filipe
Publikováno v:
Life, Vol 13, Iss 12, p 2249 (2023)
Feline core vaccines strongly recommended for all cats are against Feline panleukopenia virus (FPV), Felid herpesvirus type 1 (FeHV-1), and Feline calicivirus (FCV), but cats can be classified as low- and high-risk based on their lifestyle. The aim o
Externí odkaz:
https://doaj.org/article/1dbb43e463724c70ab5933b0c1493ea8
Autor:
Annalisa Trama, Lisa Licitra, Stefano Cavalieri, Simone Bonfarnuzzo, Paolo Baili, Antonio Ciarfella, Pablo Parente, Giovanni Almadori, Mohssen Ansarin, Almalina Bacigalupo, Philipp Baumeister, Bertrand Baujat, Paolo Bossi, Elisa Cavalera, Maria Cecilia Cercato, Francois Dieleman, Nicolas Fakhry, Virginia Ferraresi, Francesca Gaino, Danilo Galizia, Jana Halamkova, Elina Halme, Jose Hardillo, Benedikt Hofauer, Emma Kinloch, Lorenzo Livi, Laura Deborah Locati, Stefan Mattheis, Giuseppe Mercante, Aurora Mirabile, Gabriele Molteni, Ester Orlandi, Roberto Persio, Stefania Sciallero, Ludi Smeele, Marta Tagliabue, Valentino Valentini, Carla Van Harpen, Christoph Benedikt Westphalen, Laura Botta
Publikováno v:
PLoS ONE, Vol 18, Iss 3, p e0283071 (2023)
IntroductionCare for head and neck cancers is complex in particular for the rare ones. Knowledge is limited and histological heterogeneity adds complexity to the rarity. There is a wide consensus that to support clinical research on rare cancer, clin
Externí odkaz:
https://doaj.org/article/874785dfe26a4d4f844fd478640270be
Autor:
Juan B. García, Julia Feliz, M. Teresa Díez, Aurora Mira, Pilar Hernández, José R. Tormo, Mar DeAntonio, Fernando Pelaez
Publikováno v:
Journal of industrial microbiologybiotechnology. 30(10)
The manipulation of growth conditions of microorganisms is a common strategy used by pharmaceutical companies to improve the quantities and spectra of secondary metabolites with potential therapeutic interest. In this work, the effects of fermentatio
Autor:
Valentina D. A. Corino, Marco Bologna, Giuseppina Calareso, Lisa Licitra, Mariagrazia Ghi, Gaetana Rinaldi, Francesco Caponigro, Franco Morelli, Mario Airoldi, Giacomo Allegrini, Alessandra Cassano, Daris Ferrari, Aurora Mirabile, Alicia Tosoni, Danilo Galizia, Marco Merlano, Andrea Sponghini, Gabriella Moretti, Luca Mainardi, Paolo Bossi
Publikováno v:
Diagnostics, Vol 11, Iss 6, p 979 (2021)
Baseline clinical prognostic factors for recurrent and/or metastatic (RM) head and neck squamous cell carcinoma (HNSCC) treated with immunotherapy are lacking. CT-based radiomics may provide additional prognostic information. A total of 85 patients w
Externí odkaz:
https://doaj.org/article/a6f54f48f555409380e2526732486452
Autor:
Chiara Lazzari, Niki Karachaliou, Alessandra Bulotta, Mariagrazia Viganó, Aurora Mirabile, Elena Brioschi, Mariacarmela Santarpia, Luca Gianni, Rafael Rosell, Vanesa Gregorc
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 10 (2018)
Immune checkpoint inhibitors have significantly improved overall survival with an acceptable safety profile in a substantial proportion of non-small cell lung cancer (NSCLC) patients. However, not all patients are sensitive to immune checkpoint block
Externí odkaz:
https://doaj.org/article/8b2f039b0195440fa399e60bb50323eb